Zacks Investment Research on MSN4d
VRTX Provides Mixed Updates for Type 1 Diabetes Pipeline CandidatesVertex Pharmaceuticals Incorporated VRTX announced updates on its two novel investigational candidates, zimislecel (formerly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback